In Switching Generic 'Reviews' To 'Assessments' Is US FDA Changing More Than Just A Word?

MaPP revision may be just a better description of ANDA evaluations – or indicative of a broad culture change, experts tell the Pink Sheet.

RulesRegulationsBooks_1200x675

More from Generics

More from Biosimilars & Generics